Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
about
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cellsTenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?Proteinuria in paediatric patients with human immunodeficiency virus infectionNucleoside/nucleotide analogues in the treatment of chronic hepatitis BAn analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitorsComparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trialBiological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaquesPrevalence and factors associated with renal dysfunction among HIV-infected patientsLong-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.Hepatitis B Virus Immunopathology, Model Systems, and Current TherapiesHepatitis B and Renal Disease.Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Acyclic nucleoside phosphonates: a key class of antiviral drugs.Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.Tenofovir disoproxil fumarate (Viread) for the treatment of HIV infection.Tenofovir disoproxil fumarate for the treatment of HIV infection.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial.New approaches in the management of chronic hepatitis B: role of tenofovir.A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome.Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western IndiaMicroalbuminuria in HIV infection.Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and SafetyCost-effectiveness of tenofovir as first-line antiretroviral therapy in India.Tenofovir-related nephrotoxicity: case report and review of the literature.Renal Function Recovery and HIV Viral Suppression Following Tenofovir Discontinuation for Renal Impairment.Severe metabolic acidosis and renal failure in an HIV-1 patient receiving tenofovir.Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.Drug-induced nephropathy: an update.Distal renal tubular acidosis without renal impairment after use of tenofovir: a case reportTenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers.
P2860
Q24674939-C848A625-C412-48D8-9C49-3EB0BAE1F314Q26995852-48369569-850C-4648-A93E-11D1AFD38BFEQ27009315-C55969B2-B231-4AB2-BDF5-943B7761D85FQ27030828-3C3B4B0C-E058-4660-8DDF-A4231494ECD9Q28474361-63975FF3-016C-4662-847A-4C0B9EA8DFEEQ28730855-A2D3D2BE-E9EF-4BC6-8192-9C6363E8F98AQ28775900-A6CAB65E-4348-43B1-9E10-24F09183DFEAQ30484533-CDE3829B-7DF4-4EC7-82AC-29E5500D0014Q30983924-14AA9BBE-8726-4031-97AD-E2F8F23D86A1Q33559657-F6E760E5-14C6-48E2-8CE3-D0D00D587712Q33819104-81AEE126-9A6D-40C8-8EC9-A18BC399FD03Q33820144-AB0A36F0-B750-4E63-BB5A-4B4B7258ACFEQ34301401-0F21EC72-3D1E-4804-8C02-4E3544F120A2Q34409132-228037EC-3F1D-4181-9A0A-4D2148612FEEQ34464655-E50461FD-D5A4-43DA-B9E8-C88A41559080Q34478840-A84D3D80-26DE-4CB4-81ED-6F9A9B87EFF3Q34551836-4095FEC5-4A91-47D5-9827-8B22817EAD7EQ34569309-A482E5AC-9926-4B1F-A1BB-F2A05CFD4215Q34736194-1B0E4363-FAAC-45BA-8CEF-71F6DB430C9FQ34978897-DDE584BC-1D14-4D31-98AA-E22824F10E48Q35026531-B3FA4C30-442F-4A24-9D0B-8BC0ADD924ABQ35091774-53E8DFF3-21F9-43F2-95BF-EDA09D54096BQ35117296-D0FB76FF-C06B-455C-A861-CBBDBFA96763Q35293817-1DE76EBC-86E6-4BA6-860C-1EC3D4248BD8Q35535861-5EF44F56-6785-4168-A08E-AF99687178D5Q35575721-BBB7FAA5-ED1E-4C34-99FC-808290F39E8CQ35709802-C9A11330-BB1F-4383-978C-B165FA0D84D3Q35748339-532AB4D0-57FF-4DC1-885A-E231B0AC99A6Q35852636-537696D2-7284-4E79-B8E6-D9F612486333Q35891568-88F4AF63-278B-4B49-BF34-69F3C0DF69E5Q35939695-FB0C371C-33C8-4D31-87CE-242FC9285AE3Q36088274-C6E8CC21-AE6D-4A43-BA00-CCA661B1A49FQ36108952-21D23DB6-4E4F-41FE-8E19-7CA769284186Q36154208-556818C8-1AB0-4BF0-BC46-11A552BD3B3FQ36191026-CB7F05C6-8D42-47EB-9AF9-95DF622EBFC7Q36198804-3E5198C4-A5A9-447D-AD85-3AE51FF23973Q36342389-D73EBC3E-B31C-4BAE-B4A7-F250377F8FF1Q36407276-401E10C1-9B0E-4EA7-A3A4-F0CA0830C592Q36451062-3495350F-A280-447E-8879-ED44E8573F0EQ36558253-BE26F8E1-F9D3-42D1-AF49-EC799DB22AB4
P2860
Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@en
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@nl
type
label
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@en
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@nl
prefLabel
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@en
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@nl
P2093
P2860
P356
P1476
Tenofovir-related nephrotoxici ...... ephrogenic diabetes insipidus.
@en
P2093
Alexandre Karras
André Furco
Anne Bourgarit
Christophe Legendre
Daniel Sereni
Dominique Droz
Frank Martinez
Jean-Michel Molina
Matthieu Lafaurie
P2860
P304
P356
10.1086/368314
P407
P577
2003-04-04T00:00:00Z